TC
PDSB icon

Truvestments Capital’s PDS Biotechnology PDSB Stock Holding History

Truvestments Capital’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$396 Hold
655
– – ﹤0.01% 1099
2025
Q4 		$504 Hold
655
– – ﹤0.01% 951
2025
Q3 		$662 Sell
655
-456
-41% -$536 ﹤0.01% 967
2025
Q2 		$1.48K Hold
1,111
– – ﹤0.01% 864
2025
Q1 		$1.32K Hold
1,111
– – ﹤0.01% 912
2024
Q4 		$1.81K Hold
1,111
– – ﹤0.01% 854
2024
Q3 		$4.24K Buy
+1,111
New +$3.71K ﹤0.01% 702
2024
Q2 		– Sell
-1,372
Closed -$5.43K – 543
2024
Q1 		$5.43K Hold
1,372
– – ﹤0.01% 547
2023
Q4 		$6.82K Hold
1,372
– – ﹤0.01% 556
2023
Q3 		$6.93K Hold
1,372
– – ﹤0.01% 478
2023
Q2 		$6.9K Hold
1,372
– – ﹤0.01% 493
2023
Q1 		$8.44K Buy
1,372
+717
+109% +$5.87K ﹤0.01% 452
2022
Q4 		$8.65K Hold
655
– – ﹤0.01% 476
2022
Q3 		$2K Hold
655
– – ﹤0.01% 566
2022
Q2 		$2K Buy
+655
New +$3.11K ﹤0.01% 571
2022
Q1 		– Sell
-655
Closed -$5K – 435
2021
Q4 		$5K Hold
655
– – ﹤0.01% 487
2021
Q3 		$10K Hold
655
– – 0.01% 383
2021
Q2 		$8K Hold
655
– – ﹤0.01% 415
2021
Q1 		$3K Buy
+655
New +$2.64K ﹤0.01% 575

Other funds holding PDSB

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Truvestments Capital's PDSB Position: Q1 2026 in Review

Truvestments Capital held its PDS Biotechnology (PDSB) position steady in Q1 2026 at 655 shares worth $396. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Truvestments Capital first reported a position in PDSB in Q1 2021 and has held it in 19 quarters since. The position peaked at $10K in Q3 2021. 41 funds tracked by Wall St. Rank hold PDSB as of Q1 2026.

  • Truvestments Capital held 655 shares of PDS Biotechnology worth $396 as of Q1 2026.
  • Truvestments Capital left its PDS Biotechnology share count unchanged in Q1 2026.
  • PDS Biotechnology made up ﹤0.01% of Truvestments Capital's portfolio in Q1 2026, its #1099 holding.
  • Truvestments Capital first reported a position in PDS Biotechnology in Q1 2021 and has held it in 19 quarters since.
  • Truvestments Capital's PDS Biotechnology position peaked at $10K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held PDS Biotechnology as of Q1 2026.

Based on Truvestments Capital's 13F filing for Q1 2026, filed 13 May 2026.